| Artificial intelligence in drug discovery and development KK Mak, YH Wong, MR Pichika Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, 1-38, 2023 | 861 | 2023 |
| Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer D Kalyane, N Raval, R Maheshwari, V Tambe, K Kalia, RK Tekade Materials Science and Engineering: C 98, 1252-1276, 2019 | 677 | 2019 |
| Importance of physicochemical characterization of nanoparticles in pharmaceutical product development N Raval, R Maheshwari, D Kalyane, SR Youngren-Ortiz, MB Chougule, ... Basic fundamentals of drug delivery, 369-400, 2019 | 358 | 2019 |
| Development of metronidazole loaded chitosan nanoparticles using QbD approach—A novel and potential antibacterial formulation N Sreeharsha, K Rajpoot, M Tekade, D Kalyane, AB Nair, KN Venugopala, ... Pharmaceutics 12 (10), 920, 2020 | 39 | 2020 |
| Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities N Raval, A Kumawat, D Kalyane, K Kalia, RK Tekade Drug Discovery Today 25 (5), 862-878, 2020 | 37 | 2020 |
| Green graphene nanoplates for combined photo-chemo-thermal therapy of triple-negative breast cancer A Gadeval, R Maheshwari, N Raval, D Kalyane, K Kalia, RK Tekade Nanomedicine 15 (6), 581-601, 2020 | 35 | 2020 |
| Artificial intelligence in the pharmaceutical sector: current scene and future prospect D Kalyane, G Sanap, D Paul, S Shenoy, N Anup, S Polaka, V Tambe, ... The future of pharmaceutical product development and research, 73-107, 2020 | 32 | 2020 |
| Reinforced electrospun nanofiber composites for drug delivery applications N Anup, T Chavan, S Chavan, S Polaka, D Kalyane, SN Abed, ... Journal of Biomedical Materials Research Part A 109 (10), 2036-2064, 2021 | 30 | 2021 |
| Reactive oxygen nano-generators for cancer therapy D Kalyane, D Choudhary, S Polaka, H Goykar, T Karanwad, K Rajpoot, ... Progress in Materials Science 130, 100974, 2022 | 23 | 2022 |
| Integrated nanomaterials for non-invasive photothermal therapy of rheumatoid arthritis A Gadeval, S Chaudhari, SP Bollampally, S Polaka, D Kalyane, ... Drug discovery today 26 (10), 2315-2328, 2021 | 21 | 2021 |
| Surface modifications of biomaterials and their implication on biocompatibility N Raval, D Kalyane, R Maheshwari, RK Tekade Biomaterials and Bionanotechnology, 639-674, 2019 | 21 | 2019 |
| NanoGold-core dendrimeric seeds for combined chemo-, photothermal-, and photodynamic therapy of cancer S Mahajan, N Raval, D Kalyane, N Anup, R Maheshwari, V Tambe, ... Journal of Drug Delivery Science and Technology 58, 101814, 2020 | 19 | 2020 |
| Nanomaterials assisted chemo-photothermal therapy for combating cancer drug resistance V Patel, C Rajani, V Tambe, D Kalyane, N Anup, PK Deb, K Kalia, ... Journal of Drug Delivery Science and Technology 70, 103164, 2022 | 18 | 2022 |
| Recent advancements and future submissions of silica core-shell nanoparticles D Kalyane, N Kumar, N Anup, K Rajpoot, R Maheshwari, P Sengupta, ... International Journal of Pharmaceutics 609, 121173, 2021 | 15 | 2021 |
| Copolymers and block copolymers in drug delivery and therapy N Raval, D Kalyane, R Maheshwari, RK Tekade Basic fundamentals of drug delivery, 173-201, 2019 | 13 | 2019 |
| Glucosamine-conjugated nanoseeds for chemo-magneto hyperthermia therapy of cancer A Patharkar, N Raval, D Kalyane, V Tambe, N Anup, N More, G Kapusetti, ... Journal of Drug Delivery Science and Technology 61, 102295, 2021 | 10 | 2021 |
| Photothermal therapy as emerging combinatorial therapeutic approach C Rajani, V Patel, P Borisa, T Karanwad, S Polaka, D Kalyane, ... The future of pharmaceutical product development and research, 297-339, 2020 | 10 | 2020 |
| Prodrug design for improving the biopharmaceutical properties of therapeutic drugs D Choudhary, H Goykar, D Kalyane, N Sreeharsha, RK Tekade The Future of Pharmaceutical Product Development and Research, 179-226, 2020 | 9 | 2020 |
| Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease S Chawla, D Kalyane, V Tambe, PK Deb, K Kalia, RK Tekade Drug Discovery Today 25 (2), 392-405, 2020 | 8 | 2020 |
| CD44-receptor targeted gold-doxorubicin nanocomposite for pulsatile chemo-photothermal therapy of triple-negative breast cancer cells D Kalyane, S Polaka, N Vasdev, RK Tekade Pharmaceutics 14 (12), 2734, 2022 | 5 | 2022 |
Dr. Rakesh K. Tekade (Associate Prof...NIPER-A, IIT-Jammu, UTSouthwestern Texas (USA); University of Hawaii (USA), UCLan (UK), IMU-MalaysiaAdresse e-mail validée de niperahm.ac.in
